Effects of working memory training in patients with Parkinson's disease without cognitive impairment: A randomized controlled trial

2020 ◽  
Vol 72 ◽  
pp. 13-22 ◽  
Author(s):  
Anja Ophey ◽  
Kathrin Giehl ◽  
Sarah Rehberg ◽  
Carsten Eggers ◽  
Paul Reker ◽  
...  
2020 ◽  
Vol 12 ◽  
pp. 117957351989946 ◽  
Author(s):  
Kathrin Giehl ◽  
Anja Ophey ◽  
Paul Reker ◽  
Sarah Rehberg ◽  
Jochen Hammes ◽  
...  

Background: Cognitive impairment is a very frequent and severe nonmotor symptom of Parkinson’s disease (PD). Early intervention in this at-risk group for cognitive decline may be crucial for long-term preservation of cognitive functions. Computerized working memory training (WMT) has been proven beneficial in non-PD patient populations, but such evidence is still needed for patients with PD. Objective: This study aimed to evaluate the effect of WMT on visuo-spatial working memory (WM) in cognitively unimpaired patients with PD. Methods: A single-blind randomized controlled trial encompassing 76 patients with PD but no cognitive impairment according to level II diagnostic criteria was conducted. Thirty-seven patients engaged in home-based adaptive WMT 5 times per week for a period of 5 weeks, whereas the remaining patients were in the waiting list arm of the study (control group [CG]). Working memory performance was evaluated using a computerized task before and after intervention and at 14-week follow-up, allowing to quantify the precision of WM on a continuous scale, ie, to test not only if an item was remembered but also how well the location of this item was retained. Results: Coincidently, the WMT group showed slightly worse WM performance compared with the CG at baseline, which was ameliorated after WMT. This training-induced effect remained stable until follow-up. Conclusion: Patients showing relatively low WM performance, despite not formally diagnosable as Parkinson’s disease with mild cognitive impairment (PD-MCI), seem to benefit from home-based WMT. Thus, WMT could potentially be implemented in future trials as a time- and cost-efficient route to counteract subtle cognitive changes in early disease stages. Trial registration: German Clinical Trial Register (drks.de, DRKS00009379)


2011 ◽  
Vol 17 (6) ◽  
pp. 546-563 ◽  
Author(s):  
Bradley S. Gibson ◽  
Dawn M. Gondoli ◽  
Ann C. Johnson ◽  
Christine M. Steeger ◽  
Bradley A. Dobrzenski ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document